Skip to Content
  • Previous Rank714
  • Revenues ($M)$3,551.10
  • Revenue Percent Change15.1%
  • Profits ($M)$443.3
  • Profits Percent Change11%
  • Assets ($M)$13,583.30
  • Employees2,525
  • Market Value — as of March 29, 2018 ($M)$24,784.10
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Ludwig N. Hantson
CEO Title
Chairman & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
New Haven, Conn.
Websitehttp://www.alexion.com
Years on Fortune 500 List-
Employees2,525

Alexion Pharmaceuticals Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$3,551.1015.1%
Profits ($M)$443.311%
Assets ($M)$13,583.30-
Total Stockholder Equity ($M)$8,893.10-
Market Value — as of March 29, 2018 ($M)$24,784.10-

Profit Ratios

Profit as % of Revenues12.5%
Profits as % of Assets3.3%
Profits as % of Stockholder Equity5%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)1.97
EPS % Change (from 2016)11.9%
EPS % Change (5 year annual rate)9%
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2017)-2.3%
Total Return to Investors (5 year, annualized)5%
Total Return to Investors (10 year, annualized)20.4%